TNFSF11 and osteoporosis: Currently, available osteoporosis therapies for men in India encompass antiresorptive such as alendronate, ibandronate, risedronate, and zoledronic acid, anabolic agent teriparatide, and a fully-humanized monoclonal antibody RANKL inhibitor denosumab [7].